Enzo Biochem (ENZ) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-1.47M
Depreciation and amortization of property, plant and equipment	515K
Amortization of intangible assets	412K
Provision for uncollectible accounts receivable	669K
Income tax benefit	0
Share based compensation charges	151K
Share based 401(k) employer match expense
Deferred revenue recognized
Foreign currency transaction loss (gain)
Accounts receivable	-150K
Inventories	-298K
Prepaid expenses	137K
Accounts payable – trade	-522K
Accrued liabilities
Other current liabilities
Other liabilities
Total adjustments	1.14M
Net cash used in operating activities	-333K
Purchases of short term investments
Maturities of short term investments
Capital expenditures	-514K
Security deposits and other
Earn-out payment
Net cash (used in) provided by investing activities	-514K
Installment loan payments	-146K
Net cash used in financing activities	303K
Effect of exchange rate changes on cash and cash equivalents	-19K
(Decrease) increase in cash and cash equivalents	-563K
Cash and cash equivalents - beginning of period	67.78M
Cash and cash equivalents - end of period	67.21M

Entities mentioned with ENZ

View All Entities